Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators

Annual Review of Pharmacology and Toxicology

Volumn 40, Issue , 2000, Pages 491-518

  Corton, J Christopher ^a   Anderson, Steven P ^a,b   Stauber, Anja ^a  

^a CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

Growth suppression; Hepatocarcinogenesis; Inflammation

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 4 [4 [3 (4 ACETYL 3 HYDROXY 2 PROPYLPHENOXY)PROPOXY]PHENOXY]ACETIC ACID; 5 (2,4 DIOXO 5 THIAZOLIDINYLMETHYL) 2 METHOXY N [4 (TRIFLUOROMETHYL)BENZYL]BENZAMIDE; 5,8,11,14 ICOSATETRAYNOIC ACID; ACYL COENZYME A OXIDASE; ANTILIPEMIC AGENT; BINDING PROTEIN; CELL NUCLEUS RECEPTOR; CLOFIBRATE; DNA; FATTY ACID; GEMFIBROZIL; GW 0072; GW 2331; GW 2433; ICOSANOID; L 764406; LEUKOTRIENE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; NETOGLITAZONE; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXISOME PROLIFERATOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHTHALIC ACID ESTER; PIRINIXIC ACID; PREALBUMIN; PROSTAGLANDIN; PROTEIN; RETINOID X RECEPTOR; ROSIGLITAZONE; STEROID RECEPTOR COACTIVATOR 1; TOMELUKAST; TRICHLOROACETIC ACID; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERLUKAST;

BINDING AFFINITY; CANCER GROWTH; CANCER INHIBITION; DNA BINDING; DNA RESPONSIVE ELEMENT; DRUG RECEPTOR BINDING; GENE EXPRESSION; HUMAN; INFLAMMATION; LIVER CARCINOGENESIS; NONHUMAN; OXIDATIVE STRESS; PEROXISOME; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; HUMANS; INFLAMMATION; LIVER NEOPLASMS; PEROXISOME PROLIFERATORS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION FACTORS;

EID: 0034034671     PISSN: 03621642     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pharmtox.40.1.491     Document Type: Review

References (7)

1. Lock EA, Mitchell AM, Elcombe CR. 1989. Biochemical mechanisms of induction of hepatic peroxisome proliferation. Anna. Rev. Pharmacol. Toxicol. 29:145-63
2. Reddy JK, Azarnoff DL. 1980. Hypolipidemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature 283:397-98
3. Lapinskas PJ, Corton JC. 1998. Molecular mechanisms of hepatocarcinogenic peroxisome proliferators. In Molecular Biology of the Toxic Response, ed. A Puga, KB Wallace, pp. 219-53. Philadelphia, PA: Taylor & Francis
4. Staels B, Dallongeville J, Auwerx J, Schoonjans K, Leithersdort E, Fruchart JC. 1998. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 98:2088-93
5. Kliewer SA, Willson TM. 1998. The nuclear receptor PPARgamma-bigger than fat. Curr. Opin. Genet. Dev. 5:576-81
6. Spiegelman BM, Flier, JS. 1996. Adipogenesis and obesity: rounding out the big picture. Cell 87:337-89
7. Spiegelman BM. 1998. PPARgamma in monocytes: less pain, any gain? Cell 93:153-55